Posted on

How to Cope With Medicare’s Rising Costs

Aduhelm will be administered by health care providers, and thus will be covered under Medicare Part B, rather than the Part D prescription drug program. A spokesman for the Centers […]




Posted on

F.D.A. Seeks Investigation of Its Own Alzheimer’s Drug Approval

The Food and Drug Administration on Friday called for a federal investigation of the process that led to the approval of a new drug for Alzheimer’s disease that has spurred […]